Home » Topics » Regulatory

Regulatory
RSS

Nycomed Amersham receives approvable letter for extended use of Myoview

Feb. 29, 2000

Angiotech announces promising results from phase I/II SPMS study

Feb. 29, 2000

Extended-release metformin shows good phase I results

Feb. 28, 2000

Allergan and Dura enter commercialization agreement for multiple products

Feb. 25, 2000

Use of FK-506 as topical analgesic disclosed

Feb. 25, 2000

Nastech's intranasal apomorphine compared to Viagra in phase II pilot trial

Feb. 25, 2000

New Videx capsule formulation approved in France

Feb. 25, 2000

Remicade recommended for approval in E.U. for treatment of rheumatoid arthritis

Feb. 24, 2000

Nastech's NDA for intranasal scopolamine not accepted for filing

Feb. 24, 2000

Pregabalin now claimed for renal colic-associated pain

Feb. 24, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Medline raises $6.3B in fourth med-tech IPO of December
BioWorld MedTech
Medline Inc. returned to the public markets with a blockbuster IPO of $6.26 billion, reportedly this year’s largest IPO globally. The upsized offering of more...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
Vitesse finesse pays off: DBV wins in peanut allergy phase III
BioWorld
DBV Technologies SA’s pivotal phase III trial with the Viaskin Peanut allergy patch came through for the company, and officials plan a BLA filing with the U.S....
Acryl raises $28M IPO, aiming to bridge medical divide with AI
BioWorld MedTech
Acryl Inc. debuted on South Korea’s Kosdaq Dec. 16, raising ₩42.12 billion ($28.5 million) in an IPO. Shares (KOSDAQ:0007C0) closed at ₩67,000 on the first day,...